180 related articles for article (PubMed ID: 32488815)
1. Psycho-neuro-endocrino-immunologic issues in multiple sclerosis: a critical review of clinical and therapeutic implications.
Anagnostouli M; Markoglou N; Chrousos G
Hormones (Athens); 2020 Dec; 19(4):485-496. PubMed ID: 32488815
[TBL] [Abstract][Full Text] [Related]
2. Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.
Amato MP; Portaccio E
CNS Drugs; 2015 Mar; 29(3):207-20. PubMed ID: 25773609
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy and multiple sclerosis: the children of PRIMS.
Vukusic S; Confavreux C
Clin Neurol Neurosurg; 2006 Mar; 108(3):266-70. PubMed ID: 16413965
[TBL] [Abstract][Full Text] [Related]
4. Female sex hormones and multiple sclerosis.
Trenova AG; Manova MM; Zahariev ZI; Vasileva TV
Folia Med (Plovdiv); 2004; 46(4):11-5. PubMed ID: 15962809
[TBL] [Abstract][Full Text] [Related]
5. Patient awareness about family planning represents a major knowledge gap in multiple sclerosis.
Rasmussen PV; Magyari M; Moberg JY; Bøgelund M; Jensen UFA; Madsen KG
Mult Scler Relat Disord; 2018 Aug; 24():129-134. PubMed ID: 30005355
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D as an immune modulator in multiple sclerosis, a review.
Smolders J; Damoiseaux J; Menheere P; Hupperts R
J Neuroimmunol; 2008 Feb; 194(1-2):7-17. PubMed ID: 18177949
[TBL] [Abstract][Full Text] [Related]
7. An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple Sclerosis.
Vaughn C; Bushra A; Kolb C; Weinstock-Guttman B
CNS Drugs; 2018 Feb; 32(2):161-178. PubMed ID: 29508244
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy, sex and hormonal factors in multiple sclerosis.
Miller DH; Fazekas F; Montalban X; Reingold SC; Trojano M
Mult Scler; 2014 Apr; 20(5):527-36. PubMed ID: 24446387
[TBL] [Abstract][Full Text] [Related]
9. We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - No.
Hellwig K
Mult Scler; 2019 Feb; 25(2):189-190. PubMed ID: 30346230
[No Abstract] [Full Text] [Related]
10. We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - Yes.
Alvarez E; Mowry EM
Mult Scler; 2019 Feb; 25(2):187-188. PubMed ID: 30346221
[No Abstract] [Full Text] [Related]
11. We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - Commentary.
Bove R
Mult Scler; 2019 Feb; 25(2):190-192. PubMed ID: 30346219
[No Abstract] [Full Text] [Related]
12. Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis.
Marques VD; Passos GRD; Mendes MF; Callegaro D; Lana-Peixoto MA; Comini-Frota ER; Vasconcelos CCF; Sato DK; Ferreira MLB; Parolin MKF; Damasceno A; Grzesiuk AK; Muniz A; Matta APDC; Oliveira BES; Tauil CB; Maciel DRK; Diniz DS; Corrêa EC; Coronetti F; Jorge FMH; Sato HK; Gonçalves MVM; Sousa NAC; Nascimento OJM; Gama PDD; Domingues R; Simm RF; Thomaz RB; Morales RR; Dias RM; Apóstolos-Pereira SD; Machado SCN; Junqueira TF; Becker J
Arq Neuropsiquiatr; 2018 Aug; 76(8):539-554. PubMed ID: 30231128
[TBL] [Abstract][Full Text] [Related]
13. The influence of immunomodulation on psycho-neuroimmunological functions in benign multiple sclerosis.
Haase CG; Tinnefeld M; Faustmann PM
Neuroimmunomodulation; 2004; 11(6):365-72. PubMed ID: 15467351
[TBL] [Abstract][Full Text] [Related]
14. An overview of pregnancy-related issues in patients with multiple sclerosis.
Pozzilli C; Pugliatti M;
Eur J Neurol; 2015 Oct; 22 Suppl 2():34-9. PubMed ID: 26374512
[TBL] [Abstract][Full Text] [Related]
15. The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS).
Alwan S; Chambers CD; Armenti VT; Sadovnick AD
Mult Scler Relat Disord; 2015 Jan; 4(1):6-17. PubMed ID: 25787048
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of multiple sclerosis: the state of the art.
Karussis D
BioDrugs; 2013 Apr; 27(2):113-48. PubMed ID: 23423844
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for neurological, obstetrical and gynaecological care in women with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society.
Kalinowska A; Kułakowska A; Adamczyk-Sowa M; Czajkowski K; Kurowska K; Pietrzak B; Radziszewski P; Rejdak K; Bartosik-Psujek H
Neurol Neurochir Pol; 2020; 54(2):125-137. PubMed ID: 32083716
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Wingerchuk DM; Carter JL
Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
[TBL] [Abstract][Full Text] [Related]
19. Reproductive Issues in MS.
Houtchens MK; Kaplan TB
Semin Neurol; 2017 Dec; 37(6):632-642. PubMed ID: 29270936
[TBL] [Abstract][Full Text] [Related]
20. Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis.
Cree BA
Mult Scler; 2013 Jun; 19(7):835-43. PubMed ID: 23319073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
